An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to Italian ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

If we want our vaccine production process to be more robust and faster, we’ll have to stop relying on chicken eggs. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech ...

In this week's episode of "The Top Line," we’re looking at what goes into manufacturing and supply of flu vaccines. Fierce Pharma’s Zoey Becker chats with Stefan Merlo, vice president of commercial ...

LONDON (MarketWatch) -- Vical Inc. said that it has been awarded a 3 year grant worth $6.0 million from the National Institute of Allergy and infectious Diseases to further develop a DNA vaccine ...

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as next-generation technology.

In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. BERLIN (AP) — German vaccine maker BioNTech, ...

The "GMP (Good Manufacturing Practice) Principles in Vaccine Manufacturing Training Course (Dec 10th - Dec 11th, 2025)" training has been added to ResearchAndMarkets.com's offering. In this two-day ...